For individuals who are not using GLP-1 medications due to reasons such as gastrointestinal side effects, high costs, or limited insurance coverage, natural GLP-1 inducers may offer a viable alternative
All drugs show improvement during maintenance dosing: CT-388 nausea dropped from 83% (titration) to 54% (maintenance) Semaglutide and tirzepatide GI events are described as "transient" and occurring "primarily during dose escalation" Slower titration schedules generally reduce GI severity This is clinically relevant: patients who tolerate the first 4-8 weeks of dose escalation will likely experience manageable side effects long-term
As glycaemia already underwent alterations following OB injections (prior to the administration of glucose), the AUC was measured from baseline (before OB injections, t-12 min) until t30 following insulin delivery (t0)
Consequently, while triple agonists represent an important advancement in obesity pharmacotherapy, their safety, tolerability, and long-term developmental effects in adolescents remain unknown
Foods that are bland, low in fat, and easy to digest tend to be best tolerated during GLP-1 nausea
